CCI
EW icon

Credit Capital Investments’s Edwards Lifesciences EW Stock Holding History

Credit Capital Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,612
Closed -$389K – 49
2023
Q3 		$389K Buy
+5,612
New +$451K 0.52% 37
2022
Q4 		– Sell
-5,135
Closed -$424K – 64
2022
Q3 		$424K Buy
+5,135
New +$494K 0.57% 30
2022
Q2 		– Sell
-2,100
Closed -$247K – 64
2022
Q1 		$247K Buy
+2,100
New +$236K 0.23% 59

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Capital Investments's EW Position: Q4 2023 in Review

Credit Capital Investments sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 5,612 shares — an estimated $389K sold.

Credit Capital Investments first reported a position in EW in Q1 2022 and held it in 3 quarters. The position peaked at $424K in Q3 2022. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Credit Capital Investments reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Credit Capital Investments sold 5,612 Edwards Lifesciences shares in Q4 2023, an estimated $389K.
  • Credit Capital Investments first reported a position in Edwards Lifesciences in Q1 2022 and held it in 3 quarters.
  • Credit Capital Investments's Edwards Lifesciences position peaked at $424K in Q3 2022.
  • 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Credit Capital Investments's 13F filing for Q4 2023, filed 14 Feb 2024.